Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Medtronic Enters Anastomotic Connector Field, Buys Coalescent For U-Clip

This article was originally published in The Gray Sheet

  • News

Executive Summary

Medtronic's acquisition of Coalescent Surgical provides an immediate entry to the U.S. anastomotic device market and allows the firm to bypass near-term regulatory delays for its MVP system

You may also be interested in...



Cardio Panel To Review Cardica’s Anastomotic Connector, Get CoA Update

Cardica, Inc.'s PAS-Port coronary proximal anastomosis device will be reviewed by FDA's Circulatory System Devices Panel April 22

Cardio Panel To Review Cardica’s Anastomotic Connector, Get CoA Update

Cardica, Inc.'s PAS-Port coronary proximal anastomosis device will be reviewed by FDA's Circulatory System Devices Panel April 22

Mechanical Valve Divestiture Is Defining Move For MedicalCV’s New CEO

MedicalCV will conduct an IDE clinical study to investigate its Atrilaze soft tissue ablation system for cardiac arrhythmias, following an initial 510(k) clearance

Table

View full table

Tags:
Latest Headlines

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

See All
UsernamePublicRestriction

Register

MT020878

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By